Source: Citybizlist

Creyon: Creyon Bio Appoints COO Jason Ferrone, JD, And CFO Robert Muir

Creyon Bio, Inc., a drug development company engineering Oligonucleotide-Based Medicines (OBMs) to develop novel gene-centric medicines faster and at lower... Read MoreThe post Creyon Bio Appoints COO Jason Ferrone, JD, And CFO Robert Muir appeared first on citybiz.

Read full article »

Creyon's Competitors | Creyon's News | Creyon's Financials

Followers on Owler

Est. Annual Revenue

$100K-5.0M

Est. Employees

1-25

President & CEO

Christopher Hart

CEO Approval Rating

- -/100

Creyon is a California-based preclinical stage company that researches and commercializes oligonucleotide medicines for the treatment of respiratory diseases.